| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.27 | 0.02 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.05 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.2 | 0.3 |